Mesa Laboratories, Inc. (MLAB)

USD 129.99

(-1.77%)

Market Cap (In USD)

706.03 Million

Revenue (In USD)

216.18 Million

Net Income (In USD)

-254.24 Million

Avg. Volume

38.65 Thousand

Currency
USD
Country
Technology
Open
-
Prev. Close
-
Day Range
-
Year Range
83.68-141.17
PE
-
EPS
-
Beta Value
0.865
ISIN
US59064R1095
CUSIP
59064R109
CIK
724004
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Technology
Industry
Hardware, Equipment & Parts
CEO
Mr. Gary M. Owens
Employee Count
-
Website
https://www.mesalabs.com
Ipo Date
1984-02-29
Details
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.